Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study

Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study

Abstract Aims/Introduction Given the mechanism of action of sodium–glucose cotransporter 2 inhibitors (SGLT2is), these drugs can also reduce bone density and increase fracture risk. We aimed to identify and characterize fracture‐related adverse events that are associated with SGLT2is. Materials and...

Full description

Bibliographic Details
Main Authors: Bin Zhao, Juan Shen, Jun Zhao, Hui Pan
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Journal of Diabetes Investigation
Subjects:
Fracture
Pharmacovigilance
Sodium–glucose cotransporter 2 inhibitors
Online Access:https://doi.org/10.1111/jdi.13481

Internet

https://doi.org/10.1111/jdi.13481

Similar Items